Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests
Abstract
:1. Generalities about Honeybees
2. Main Compounds of Bee Venom
2.1. Melittin
2.2. Apamin
2.3. Mast Cell Degranulating (MCD) Peptide
2.4. Adolapin
2.5. Phospholipase A2
2.6. Hyaluronidase
3. Bioactivities and Therapeutic Applications of Bee Venom and Its Major Compounds
3.1. Anti-Inflammatory Potential
3.2. BV Application for the Treatment of Neurodegenerative Diseases
3.2.1. Parkinson’s Disease
3.2.2. Alzheimer’s Disease
3.2.3. Amyotrophic Lateral Sclerosis
3.3. BV and/or Melittin Applications in Cancer
3.4. Antiviral and Antibacterial Properties
4. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Greenleaf, S.S.; Kremen, C. Wild bees enhance honey bees’ pollination of hybrid sunflower. Proc. Natl. Acad. Sci. USA 2006, 103, 13890–13895. [Google Scholar] [CrossRef] [PubMed]
- Fratellone, P.M. Apitherapy Products for Medicinal Use. J. Nutr. Food Sci. 2015, 5. [Google Scholar] [CrossRef] [PubMed]
- Ali, M.A.A.-S.M. Studies on bee venom and its medical uses. Int. J. Adv. Res. Technol. 2012, 1, 69–83. [Google Scholar]
- El-Wahab, S.D.A.; Eita, L.H. The effectiveness of live bee sting acupuncture on depression. J. Nurs. Health Sci. 2015, 4, 19–27. [Google Scholar]
- Trumbeckaite, S.; Dauksiene, J.; Bernatoniene, J.; Janulis, V. Knowledge, attitudes, and usage of apitherapy for disease prevention and treatment among undergraduate pharmacy students in Lithuania. Evid.-Based Complement. Altern. Med. 2015, 9. [Google Scholar] [CrossRef] [PubMed]
- Hellner, M.; von Georgi, D.W.R.; Münstedt, K. Apitherapy: Usage and experience in German beekeepers. Evid.-Based Complement. Altern. Med. 2007, 5, 475–479. [Google Scholar] [CrossRef]
- Lee, J.A.; Son, M.J.; Choi, J.; Yun, K.J.; Jun, J.H.; Lee, M.S. Bee venom acupuncture for rheumatoid arthritis: A systematic review protocol. Bmj Open 2014, 4. [Google Scholar] [CrossRef] [PubMed]
- Zhang, S.; Liu, Y.; Ye, Y.; Wang, X.R.; Lin, L.T.; **-pattern analysis for detecting fine motor skills decline in early-stage Parkinson’s disease. Sci. Rep. 2018. [Google Scholar] [CrossRef]
- Tanner, C.M.; Kamel, F.; Ross, G.W.; Hoppin, J.A.; Goldman, S.M.; Korell, M.; Marras, C.; Bhudhikanok, G.S.; Kasten, M.; Chade, A.R.; et al. Rotenone, paraquat, and Parkinson’s disease. Environ. Health Perspect. 2011, 119, 866–872. [Google Scholar] [CrossRef]
- Khalil, W.K.B.; Assaf, N.; ElShebiney, S.A.; Salem, N.A. Neuroprotective effects of bee venom acupuncture therapy against rotenone-induced oxidative stress and apoptosis. Neurochem. Int. 2015, 80, 79–86. [Google Scholar] [CrossRef]
- Alvarez-Fischer, D.; Noelker, C.; Vulinović, F.; Grünewald, A.; Chevarin, C.; Klein, C.; Oertel, W.H.; Hirsch, E.C.; Michel, P.P.; Hartmann, A. Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model. PLoS ONE 2013, 8. [Google Scholar] [CrossRef]
- Aksoz, E.; Gocmez, S.; Sahin, T.D.; Aksit, D.; Aksit, H.; Utkan, T. The protective effect of metformin in scopolamine-induced learning and memory impairment in rats. Pharm. Rep. 2019, 71, 818–825. [Google Scholar] [CrossRef]
- Sabri, O.; Sabbagh, M.N.; Seibyl, J.; Barthel, H.; Akatsu, H.; Ouchi, Y.; Senda, K.; Murayama, S.; Ishii, K.; Takao, M.; et al. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer’s disease: Phase 3 study. Alzheimers Dement. 2015, 11, 964–974. [Google Scholar] [CrossRef]
- Baek, H.; Lee, C.; Choi, D.B.; Kim, N.S.; Kim, Y.S.; Ye, Y.J.; Kim, Y.S.; Kim, J.S.; Shim, I.; Bae, H. Bee venom phospholipase A2 ameliorates Alzheimer’s disease pathology in Aβ vaccination treatment without inducing neuro-inflammation in a 3xTg-AD mouse model. Sci. Rep. 2018, 8. [Google Scholar] [CrossRef]
- Kakuda, N.; Miyasaka, T.; Iwasaki, N.; Nirasawa, T.; Wada-Kakuda, S.; Takahashi-Fujigasaki, J.; Murayama, S.; Ihara, Y.; Ikegawa, M. Distinct deposition of amyloid-β species in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry. Acta Neuropathol. Commun. 2017, 5. [Google Scholar] [CrossRef]
- Van Eldik, L.J.; Carrillo, M.C.; Cole, P.E.; Feuerbach, D.; Greenberg, B.; Hendrix, J.A.; Kennedy, M.; Kozauer, N.; Margolin, R.A.; Molinuevo, J.L.; et al. The roles of inflammation and immune mechanisms in Alzheimer’s disease. Alzheimers Dement. 2016, 2, 99–109. [Google Scholar] [CrossRef]
- Kinney, J.W.; Bemiller, S.M.; Murtishaw, A.S.; Leisgang, A.M.; Salazar, A.M.; Lamb, B.T. Inflammation as a central mechanism in Alzheimer’s disease. Alzheimers Dement. 2018, 4, 575–590. [Google Scholar] [CrossRef]
- Terry, A.V.; Buccafusco, J.J. The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and TheirImplications for Novel Drug Development. J. Pharm. Exp. Ther. 2003, 306, 821–827. [Google Scholar] [CrossRef]
- Rajagopalan, V.; Pioro, E.P. Unbiased MRI analyses identify micropathologic differences between upper motor neuron-predominant ALS phenotypes. Front. Neurosci. 2019, 13. [Google Scholar] [CrossRef]
- Boillée, S.; Yamanaka, K.; Lobsiger, C.S.; Copeland, N.G.; Jenkins, N.A.; Kassiotis, G.; Kollias, G.; Cleveland, D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006, 312, 1389–1392. [Google Scholar] [CrossRef]
- Jaarsma, D.; Haasdijk, E.D.; Grashorn, J.A.C.; Hawkins, R.; Van Duijn, W.; Verspaget, W.H.; London, J.; Holstege, J.C. Human Cu/Zn Superoxide Dismutase (SOD1) Overexpression in Mice Causes Mitochondrial Vacuolization, Axonal Degeneration, and Premature Motoneuron Death and Accelerates MotoneuronDisease in Mice Expressing a Familial AmyotrophicLateral Sclerosis Mutant SOD1. Neurobiol. Dis. 2000, 7, 623–643. [Google Scholar] [CrossRef]
- Yang, E.J.; Jiang, J.H.; Lee, S.M.; Yang, S.C.; Hwang, H.S.; Lee, M.S.; Choi, S.M. Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models. J. Neuroinflamm. 2010, 7. [Google Scholar] [CrossRef]
- Cai, M.D.; Choi, S.M.; Yang, E.J. The effects of bee venom acupuncture on the central nervous system and muscle in an animal hSOD1G93A mutant. Toxins 2015, 7, 846–858. [Google Scholar] [CrossRef]
- Jung, G.B.; Huh, J.-E.; Lee, H.J.; Kim, D.; Lee, G.J.; Park, H.K.; Lee, J.D. Anti-cancer effect of bee venom on human MDA-MB-231 breast cancer cells using Raman spectroscopy. Biomed. Opt. Express 2018, 9, 5703–5718. [Google Scholar] [CrossRef]
- Lim, H.N.; Baek, S.B.; Jung, H.J. Bee venom and its peptide component melittin suppress growth and migration of Melanoma Cells via inhibition of PI3K/AKT/mTOR and MAPK pathways. Molecules 2019, 24, 929. [Google Scholar] [CrossRef]
- Hong, J.; Lu, X.; Deng, Z.; **ao, S.; Yuan, B.; Yang, X. How Melittin inserts into cell membrane: Conformational changes, inter-peptide cooperation, and disturbance on the membrane. Molecules 2019, 24, 1775. [Google Scholar] [CrossRef]
- Liu, S.; Yu, M.; He, Y.; **ao, L.; Wang, F.; Song, C.; Sun, S.; Ling, C.; Xu, Z. Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology 2008, 47, 1964–1973. [Google Scholar] [CrossRef]
- Saidemberg, D.M.; Baptista-Saidemberg, N.B.; Palma, M.S. Chemometric analysis of Hymenoptera toxins and defensins: A model for predicting the biological activity of novel peptides from venoms and hemolymph. Peptides 2011, 32, 1924–1933. [Google Scholar] [CrossRef] [Green Version]
- Liu, X.; Chen, D.; **e, L.; Zhang, R. Effect of honey bee venom on proliferation of K1735M2 mouse melanoma cells in-vitro and growth of murine B16 melanomas in-vivo. J. Pharm Pharmacol. 2002, 54, 1083–1089. [Google Scholar] [CrossRef]
- Wang, C.; Chen, T.; Zhang, N.; Yang, M.; Li, B.; Lü, X.; Cao, X.; Ling, C. Melittin, a Major Component of Bee Venom, Sensitizes Human Hepatocellular Carcinoma Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced. Apoptosis by Activating CaMKII-TAK1-JNK/p38 and Inhibiting IkB alpha Kinase-NFkB. J. Biol Chem. 2009, 284, 3804–3813. [Google Scholar] [CrossRef]
- Zheng, J.; Lee, H.L.; Ham, Y.W.; Song, H.S.; Song, M.J.; Hong, J.T. Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B. Oncotarget 2015, 6, 44437–44451. [Google Scholar] [CrossRef]
- Zuazo-Gaztelu, I.; Casanovas, O. Unraveling the role of angiogenesis in cancer ecosystems. Front. Oncol. 2018, 8. [Google Scholar] [CrossRef]
- Rajabi, M.; Mousa, S.A. The role of angiogenesis in cancer treatment. Biomedicines 2017, 5, 34. [Google Scholar] [CrossRef]
- Gülmez, Y.; Aydın, A.; Can, I.; Tekin, S.; Cacan, E. Cellular toxicity and biological activities of honey bee (Apis mellifera L.) venom. Marmara Pharm. J. 2017, 21, 51–260. [Google Scholar]
- Soman, N.R.; Baldwin, S.L.; Hu, G.; Marsh, J.N.; Lanza, G.M.; Heuser, J.E.; Arbeit, J.M.; Wickline, S.A.; Schlesinger, P.H. Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. J. Clin. Investig. 2009, 119, 2830–2842. [Google Scholar] [CrossRef]
- Cheng, B.; Thapa, B.; Remant, K.C.; Xu, P. Dual secured nano-melittin for the safe and effective eradication of cancer cells. J. Mater. Chemb. 2015, 3, 25–29. [Google Scholar] [CrossRef]
- Jallouk, A.P.; Moley, K.H.; Omurtag, K.; Hu, G.; Lanza, G.M.; Wickline, S.A.; Hood, J.L. Nanoparticle Incorporation of Melittin Reduces Sperm and Vaginal Epithelium Cytotoxicity. PLoS ONE 2014, 9. [Google Scholar] [CrossRef]
- Hegazi, A.; Abdou, A.M.; EI-Moez, S.I.; Abd Allah, F. Evaluation of the antibacterial activity of bee venom from different sources. World Appl. Sci. J. 2014, 30, 266–270. [Google Scholar]
- Socarras, K.M.T.; Theophilus, P.A.S.; Torres, J.P.; Gupta, K.; Sapi, E. Antimicrobial Activity of Bee Venom and Melittin against Borrelia burgdorferi. Antibiot. (Basel) 2017, 6. [Google Scholar] [CrossRef]
- Perumal Samy, R.; Gopalakrishnakone, P.; Thwin, M.M.; Chow, T.K.; Bow, H.; Yap, E.H.; Thong, T.W. Antibacterial activity of snake, scorpion and bee venoms: A comparison with purified venom phospholipase A2 enzymes. J. Appl Microbiol. 2007, 102, 650–659. [Google Scholar] [CrossRef]
- Zolfagharian, H.; Babaie, M. Antimicrobial activity of bee venom and Melittin against Borrelia burgdorferi. J. Pharmacopuncture. 2016, 19, 225–230. [Google Scholar] [CrossRef]
- Uddin, M.B.; Lee, B.H.; Nikapitiya, C.; Kim, J.H.; Kim, T.H.; Lee, H.C.; Kim, C.G.; Lee, J.S.; Kim, C.J. Inhibitory effects of bee venom and its components against viruses in vitro and in vivo. J. Microbiol. 2016, 54, 853–866. [Google Scholar] [CrossRef]
- Bachis, A.; Cruz, M.I.; Mocchetti, I. M-tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T-tropic gp120 in rat striatum. Eur. J. Neurosci. 2010, 32. [Google Scholar] [CrossRef]
- Cecilio, A.B.; Caldas, S.; Oliveira, R.A.; Santos, A.S.; Richardson, M.; Naumann, G.B.; Schneider, F.S.; Alvarenga, V.G.; Estevão-Costa, M.I.; Fuly, A.L.; et al. Molecular characterization of Lys49 and Asp49 phospholipases A₂from snake venom and their antiviral activities against Dengue virus. Toxins 2013, 5, 1780–1798. [Google Scholar] [CrossRef]
- Fenard, D.; Lambeau, G.; Valentin, E.; Lefebvre, J.C.; Lazdunski, M.; Doglio, A. Secreted phospholipases A2, a new class of HIV inhibitors that block virus entry into host cells. J. Clin. Investig. 1999, 104, 611–618. [Google Scholar] [CrossRef] [Green Version]
- Fenard, D.; Lambeau, G.; Maurin, T.; Lefebvre, J.C.; Doglio, A. A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor. Mol. Pharmacol. 2001, 60, 341–347. [Google Scholar] [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wehbe, R.; Frangieh, J.; Rima, M.; El Obeid, D.; Sabatier, J.-M.; Fajloun, Z. Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests. Molecules 2019, 24, 2997. https://doi.org/10.3390/molecules24162997
Wehbe R, Frangieh J, Rima M, El Obeid D, Sabatier J-M, Fajloun Z. Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests. Molecules. 2019; 24(16):2997. https://doi.org/10.3390/molecules24162997
Chicago/Turabian StyleWehbe, Rim, Jacinthe Frangieh, Mohamad Rima, Dany El Obeid, Jean-Marc Sabatier, and Ziad Fajloun. 2019. "Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests" Molecules 24, no. 16: 2997. https://doi.org/10.3390/molecules24162997